共 26 条
A Core Outcome Set for Seamless, Standardized Evaluation of Innovative Surgical Procedures and Devices (COHESIVE) A Patient and Professional Stakeholder Consensus Study
被引:20
|作者:
Avery, Kerry N. L.
[1
,2
]
Wilson, Nicholas
[1
,2
]
Macefield, Rhiannon
[1
,2
]
McNair, Angus
[1
,2
,3
]
Hoffmann, Christin
[1
,2
]
Blazeby, Jane M.
[1
,2
,4
]
Potter, Shelley
[1
,2
,5
]
机构:
[1] Univ Bristol, Natl Inst Hlth Res Bristol Biomed Res Ctr, Bristol Ctr, Bristol Med Sch, Bristol, England
[2] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England
[3] North Bristol NHS Trust, Gastrointestinal Surg, Bristol, England
[4] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Infirm, Div Surg, Bristol, England
[5] Bristol Breast Care Ctr, North Bristol NHS Trust, Southmead Rd, Bristol, England
关键词:
core outcome set;
Delphi technique;
device approval;
operative;
outcome assessment;
surgical procedures;
D O I:
10.1097/SLA.0000000000004975
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Objective:To develop a COS, an agreed minimum set of outcomes to measure and report in all studies evaluating the introduction and evaluation of novel surgical techniques. Summary of Background Data:Agreement on the key outcomes to measure and report for safe and efficient surgical innovation is lacking, hindering transparency and risking patient harm. Methods:(I) Generation of a list of outcome domains from published innovation-specific literature, policy/regulatory body documents, and surgeon interviews; (II) Prioritization of identified outcome domains using an international, multi-stakeholder Delphi survey; (III) Consensus meeting to agree the final COS. Participants were international stakeholders, including patients/public, surgeons, device manufacturers, regulators, trialists, methodologists, and journal editors. Results:A total of 7972 verbatim outcomes were identified, categorized into 32 domains, and formatted into survey items/questions. Four hundred ten international participants (220 professionals, 190 patients/public) completed at least one round 1 survey item, of which 153 (69.5%) professionals and 116 (61.1%) patients completed at least one round 2 item. Twelve outcomes were scored "consensus in" ("very important" by >= 70% of patients and professionals) and 20 "no consensus." A consensus meeting, involvingcontext: modifications, unexpected disadvantages, device problems, technical procedure completion success, patients' experience relating to the procedure being innovative, surgeons'/operators' experience. Other domains relate to intended benefits, whether the overall desired effect was achieved and expected disadvantages. Conclusions:The COS is recommended for use in all studies before definitive randomized controlled trial evaluation to promote safe, transparent, and efficient surgical innovation.
引用
收藏
页码:238 / 245
页数:8
相关论文